Current Studies

Study Information
Location
Status
Age Range
Sex
Max Compensation
ADHD (child)
A placebo controlled study evaluating the efficacy and safety of an investigational medication for Children with ADHD
Evansville
Owensboro
Enrolling
4-5
Male/Female
Up to $1900
COPD
A phase 3 study to evaluate the efficacy and safety of two dose regimens of an investigational medication in participants with Symptomatic COPD
Bowling Green
Enrolling
40+
Male/Female
Up to $1200
DIABETES (T2DM) w/ CV RISKS
A study to evaluate the efficacy and safety of an investigation medication as a daily oral pill compared to insulin glargine injections in Adults with Type 2 Diabetes and Risk of Cardiovascular Disease
Bowling Green
Evansville
Enrolling
18+
Male/Female
Up to $6328
DIABETES (T2DM) & OBESITY
A study to assess the efficacy and safety of an investigational medicine in participants with Type 2 Diabetes and Obesity
Evansville
Enrolling
18-75
Male/Female
Up to $3600
ECZEMA (adults)
A phase 2a study of the effects of an investigational medicine in Adults with Moderate to Severe Atopic Dermatitis
Owensboro
Enrolling
18-75
Male/Female
Up to $1375
LIPOPROTEIN (a)
A study to investigate the effect of an investigational medicine on the reduction of major adverse cardiovascular events in Adults with Elevated Lipoprotein(a)
Bowling Green
Enrolling
18+
Male/Female
Up to $2150
MIGRAINES IN CHILDREN
A double blind, placebo controlled study of an investigational medicine for Pediatric Migraines
Bowling Green
Evansville
Owensboro
Enrolling
6-17
Male/Female
$200/$350
OBESITY w/ CV OUTCOMES
A study is to evaluate the efficacy of a once weekly investigational medicine on cardiovascular outcomes and the decline in kidney function in adults living with obesity.
Bowling Green
Evansville
Enrolling
45+
Male/Female
Up to $3600
RHEUMATOID ARTHRITIS
A head-to-head active comparitor study to investigate the safety and efficacy of an approved oral medication to an injectable in patients with Moderate to Severe Rheumatoid Arthritis
Evansville
Enrolling
18+
Male/Female
Up to $900
ECZEMA (adolescents & adults)
A safety and efficacy study for patients 12 years and older with Moderate to Severe Atopic Dermatitis (Eczema)
Newburgh
Coming Soon
12+
Male/Female
Up to $1250
PSORIASIS (NWB)
This is a Phase 3 study to evaluate the safety and efficacy of an investigational medicine compared with placebo in adult participants with moderate to severe plaque psoriasis.
Newburgh
Coming Soon
18+
Male/Female
Up to $1650

Contact Us

Pin It on Pinterest